Search results
YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
FOX 5 San Diego· 6 days agoYS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering ...